doi: 10.1371/journal.pcbi.1007657 52 CiesielskaAMatyjekMKwiatkowskaK
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
This plateau likely reflects metabolic adaptation to sustained appetite suppression
The cleaved N-terminal fragment of GSDME forms pores in the cell membrane, triggering pyroptosis, which is characterized by cell swelling, rupture, and the release of pro-inflammatory signals
Etiopathogenesis of cataract: An appraisal
The gap between doing it right and doing it wrong comes down to three things most guides never mention: dosing schedule, form selection, and hydration timing